Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | HER3-primed DC1 vaccine |
Synonyms | |
Therapy Description |
HER3-primed DC1 vaccine is a cancer vaccine comprising patient-derived dendritic cells targeted against ERBB3 (HER3), which potentially enhances anti-tumor immune response against ERBB3 (HER3)-expressing tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
HER3-primed DC1 vaccine | Anti-HER3 DC Vaccine | HER3-primed DC1 vaccine is a cancer vaccine comprising patient-derived dendritic cells targeted against ERBB3 (HER3), which potentially enhances anti-tumor immune response against ERBB3 (HER3)-expressing tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05504707 | Phase I | HER2-pulsed DC1 vaccine HER3-primed DC1 vaccine | DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer (DecipHER) | Recruiting | USA | 0 |